|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; 2Department of Developmental Physiology, National Institute for Physiological Sciences, Myodaiji, Okazaki; 3Core Research for the Evolutionary Science and Technology, Japan Science and Technology Corporation, Kawaguchi; and 4The Graduate University for Advanced Studies, Hayama, Japan
Submitted 1 July 2008; accepted in final form 25 August 2008
|
|
ABSTRACT |
|---|
|
4β2 nicotinic receptor subtype. The remaining 6/58 neurons exhibited not only the slower
4β2 receptor-mediated component but also a faster component that was inhibited by a specific antagonist for
7 nicotinic receptor,
-bungarotoxin. cTRNs expressing
7 nicotinic receptors tended to be smaller in size than those lacking
7 receptors. Bath application of muscarine induced two response patterns: mIN only (17/38) and mIN+ mOUT (21/38). The mIN and mOUT were mediated by M3 (plus M1) and M2 muscarinic receptors, respectively. These results suggest that a major response to cholinergic inputs to cTRNs is excitatory. This would indicate the facilitatory role of the brain stem cholinergic system in the execution of orienting behaviors including saccadic eye movements. |
|
INTRODUCTION |
|---|
|
Many neuroanatomical studies analyzed cholinergic projections to the SGI, which originate from the pedunculopontine and laterodorsal tegmental nuclei (PPTN and LDTN) in the parabrachial region of the brain stem (Beninato and Spencer 1986
; Graybiel 1978a
; Hall et al. 1989
; Illing and Graybiel 1985
; Ma et al. 1991
). Several anatomical studies using immunohistochemistry, in situ hybridization, receptor autoradiography, or immunoprecipitation have shown the expression of
3,
4,
5,
6,
7, β2, β3, and β4 nicotinic receptor (nAChR) subunits in the SC (Clarke et al. 1985
; Dominguez del Toro et al. 1994
; Gotti et al. 2006
; Perry et al. 2007
; Prusky and Cynader 1988
; Swanson et al. 1987
; Tribollet et al. 2004
; Wada et al. 1989
; Whiteaker et al. 2000
, 2002
).
4β2- and
7-like receptors are the predominant forms in the SGI, whereas
3/
6β2 receptors are mostly expressed in the superficial gray layer (SGS) (Gotti et al. 2006
; Nguyen et al. 2004
; Perry et al. 2002
, 2007
; Tribollet et al. 2004
; Whiteaker et al. 2000
). In addition, previous binding studies have reported that that M1, M2, and M3 muscarinic receptor (mAChR) subtypes are all expressed in the SC (Cortes et al. 1984
; Cymerman et al. 1987
; Frey and Howland 1992
; Hoss et al. 1990
; Levey 1993
; Miyoshi et al. 1989
; Price et al. 1986
; Zubieta and Frey 1993
).
These cholinergic inputs seem to play an important role in modulating the signal processing in the SC in a context-dependent manner. However, until recently, the physiological roles of the cholinergic inputs was not clear. Our laboratory has been analyzing the role of cholinergic inputs to the SC, especially their relation to regulation of saccadic eye movements, with different techniques. It was found that tonic activity of a group of PPTN neurons was related to a successful performance in a visually guided saccade task in awake behaving monkeys (Kobayashi et al. 2002
). Li et al. (2004)
showed that activation of M1 and M3 type mAChRs caused presynaptic inhibition of GABAergic transmission in the SGI by using the whole cell patch-clamp technique. Injection of nicotine into the monkey SGI shortened the reaction times of saccades toward the movement field of the neurons at the injection site (Aizawa et al. 1999
; Watanabe et al. 2005
). In a previous study on rodent slices, we reported that bath application of 30 µM carbachol (CCh) induced depolarization and spike firing in all the SGI neurons tested (45/45). The CCh-induced inward currents were partially suppressed by nAChR antagonist, 1 µM DHβE. Moreover, 30 µM nicotine could also induce depolarization in most of the cTRNs (Kobayashi and Isa 2002
). However, details of the receptor mechanism of the cholinergic actions are still unclear.
In our recent study, as the initial step to clarify the cholinergic action on SGI neurons, we analyzed the effect of bath application of CCh on a large population of randomly sampled SGI neurons to cover all the different response patterns. Five different patterns with various combinations of nicotinic inward (nIN), muscarinic inward (mIN), and muscarinic outward (mOUT) current responses were observed: 1) nIN only, 2) nIN + mIN, 3) nIN + mIN + mOUT, 4) nIN + mOUT, and 5) mOUT only (Sooksawate and Isa 2006
). In that study, we could identify some of the recorded cells as output neurons based on the trajectories of their axons that were stained by intracellularly injected biocytin. However, they still showed four different response patterns to CCh, which made interpretation of the role of cholinergic input difficult. In this study, we focused on the cholinergic action on a defined population of SGI output neurons, cTRNs, to clarify the role of cholinergic inputs for the control of orienting behaviors. These projection neurons were identified by retrograde labeling from the contralateral MPRF (Isa and Sasaki 2002
; Sooksawate et al. 2005b
). We first analyzed their responses to bath-applied CCh. Second, we studied the nAChR and mAChR subtypes in these identified population of SGI neurons. Based on the results, functional implication of the cholinergic inputs to the SGI will be discussed.
|
|
METHODS |
|---|
|
Retrograde labeling of identified cTRNs
cTRNs were identified by retrograde labeling as previously reported (Sooksawate et al. 2005b
). In brief, dextran-conjugated Texas red (5% in Tris-buffered saline, Molecular Probes, Eugene, OR) was unilaterally injected under xylazine/ketamine (10 mg/kg/60 mg/kg) anesthesia into the MPRF of 14- to 16-day-old Long Evan rats, 3–6 days before the acute slice experiment. After injection of the tracer, the incision was sutured, and the rat pups were allowed to be with their mother until the day of the acute slice experiment.
Slice preparations of the SC
The SC slices were obtained from 17- to 22-day-old rats that received injection of dextran-conjugated Texas red as described above. Rats were decapitated under deep ether anesthesia. Brains were quickly removed and submerged for 5 min in an ice-cold sucrose-Ringer solution containing (in mM) 234 sucrose, 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, 0.5 CaCl2, 26 NaHCO3, and 11 D-glucose, pH 7.4 (after equilibration with 95% O2-5% CO2). A small incision mark was made ipsilateral to the Texas red injection. Three hundred-micrometer-thick frontal slices were cut using a microslicer (DTK-2000, Dosaka EM, Kyoto, Japan). Slices containing the SC were incubated in a Ringer solution containing (in mM) 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, and 25 D-glucose, pH 7.4 (after equilibration with 95% O2-5% CO2) at room temperature (22–25°C) for >1 h before recording. After incubation, SC slices were placed in a recording chamber on an upright fluorescence microscope (Axioskop FS, Zeiss) and continuously superfused with the Ringer solution at a rate of 2–3 ml/min using two peristaltic pumps (Minipuls 3, Gilson). The first pump was used to superfuse the Ringer solution or drug solutions to the recording chamber. The second pump was used to pump the solution out from the chamber. The method for switching between Ringer solution and drug solution was through a manual valve. The brain stem caudal to the SC was incubated in a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer for 2–4 days and cut into frontal sections to confirm the injection site of the tracer (Fig. 1 A).
|
Whole cell patch-clamp recordings were obtained from the SGI neurons under visual control of patch pipettes using a patch clamp amplifier (EPC-7, List, Darmstadt, Germany). Retrogradely labeled cTRNs were located using epifluorescence optics and visualized with Nomarski optics and a x63, water immersion objective (Fig. 1B). Most of the recordings were obtained from neurons located in SGI, the terminal field of cholinergic input fibers (Beninato and Spencer 1986
; Graybiel 1978a
; Hall et al. 1989
; Illing and Graybiel 1985
; Ma et al. 1991
). Recording electrodes were pulled from borosilicate glass capillaries (Clark Electromedical Instruments) using a horizontal electrode puller (P-97, Sutter Instruments) and filled with an intrapipette solution containing (in mM) 140 K-gluconate, 20 KCl, 0.2 EGTA, 2 MgCl2, 2 Na2ATP, 0.5 Na3GTP, 10 HEPES, and 0.1 spermine (pH 7.3). In the experiment to identify nAChR subtypes, the pipettes were filled with solution containing (in mM) 120 Cs-gluconate, 10 CsCl, 2 MgCl2, 4 Na2ATP, 10 EGTA, 10 HEPES, and 0.1 spermine (pH 7.3). Because the liquid junction potential between the Ringer solution and the gluconate-based intrapipette solution was estimated to be –10 mV, the actual membrane potential was corrected by this value. The osmolarity of the intrapipette solution was 280–290 mOsm/l. The resistance of the electrodes was 4–7 M
in the bath solution. Depolarizing and hyperpolarizing current pulses were applied to all the cells tested, except for the neurons in the experiment to identify nAChR subtypes, with a duration of 500 ms at 40-pA steps
200 pA from two different levels of the membrane potential (–55 to –70 mV and –75 to –90 mV) set by a constant current injection. Data were acquired using a pClamp system (pClamp 8.0, Axon Instruments).
Histology and morphological analysis
In all the experiments, biocytin was dissolved in the intrapipette solution at a concentration of 5 mg/ml just before recording for later morphological analysis of the recorded neurons. The recorded cells were filled with biocytin by diffusion from the pipettes. After recordings, the slices were fixed with 4% phosphate-buffered paraformaldehyde solution for >24 h. They were processed with the avidin-biotin peroxidase method (ABC kit, Vectorlab), visualized with diaminobenzidine tetrahydrochloride (DAB; Dojin, Kumamoto, Japan), and intensified with nickel ammonium sulfate (Isa et al. 1998
; Saito and Isa 1999
). Finally, the slices were counterstained with cresyl violet or neutral red. Only cells with intact somas and proximal dendrites were drawn using a camera lucida attached to a light microscope (Olympus) and analyzed using the MetaMorph software version 6.3 (Molecular Devices).
Drugs and chemicals
All the drugs and chemicals were purchased from Sigma (St. Louis, MO) with the exception of TTX and
-conotoxin MII (
-CTX MII), which were purchased from Sankyo (Tokyo, Japan) and Tocris, respectively.
Carbachol (CCh; 30 µM), dihydro-β-erythroidine (DHβE; 1 µM), and atropine (1 µM) were used in this study as a nonselective cholinergic agonist, nAChR antagonist, and mAChR antagonist, respectively. To study fast responses of cholinergic receptor activation, 1 mM ACh was applied with air pressure pulses (20–30 psi, 30–50 ms duration) through a micropipette identical to the patch pipette to induce nicotinic currents. Muscarinic response was suppressed by 1 µM atropine added into the Ringer solution. The micropipette was placed within 50 µm of the recorded neurons.
-Bungarotoxin (
-BTX; 100 nM),
-CTX MII (50 nM), and DHβE (200 nM) were used as relatively specific antagonists for
7,
3/
6β2, and
4β2 subtypes of nAChRs, respectively, and applied to every neuron tested in order, from
-BTX,
-CTX MII, and DHβE. Muscarine (10 µM) was used as a specific agonist of mAChRs. Pirenzepine (1 µM), methoctramine (10 µM), and 4-diphenylacetoxy-N-methylpiperadine-methiodide (4-DAMP; 50 nM) were used as relatively specific antagonists of M1, M2, and M3 subtypes of mAChRs, respectively. Stock solutions of all drugs were prepared in distilled water, stored at –20°C, and diluted to their final concentrations in Ringer solution on the day of the experiment. All the drug solutions were applied to the recorded neurons via the bath superfusion system with the exception for ACh. After application of the drugs, the Ringer solution without any drugs was perfused continuously to wash out all the drugs.
The cholinergic receptor agonist (CCh or muscarine) was applied to the recorded neurons for 40–60 s. The interval between CCh and muscarine applications was 15 min to avoid desensitization and rundown of the receptors. As shown in RESULTS, the effects of DHβE and atropine did not recover within this interval; therefore they were separately applied in combination with CCh. To identify subtypes of the cholinergic receptors, the neuron was pretreated with
-BTX or
-CTX MII for >10 min, DHβE for >4 min, and pirenzepine, 4-DAMP, or methoctramine for >5 min before the additional application of the agonists. During these pretreatment times, the antagonists were applied at the appropriate concentrations in the solution containing the agonist. To prevent the effects of drugs on presynaptic elements, 0.5 µM TTX was applied after the response properties to current pulses were determined in all the experiments. We also used 10 µM bicuculline methobromide (Bic), 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and 50 µM D-2-amino-5-phosphonovaleric acid (APV) for suppression of GABAA receptors, AMPA/kainate receptors, and NMDA receptors, respectively, to exclude the possible contamination of current responses caused by these receptors. Because GABAC receptors were expressed exclusively in the superficial layers of SC (Boller and Schmidt 2003
; Boue-Grabot et al. 1998
), GABAC receptor antagonist was not added into the Ringer solution.
Data analysis
The input impedance was calculated from the steady-state voltage change in response to a –40-pA hyperpolarizing current pulse. The membrane capacitance in the whole cell configuration was measured by reading in the pClamp system after adjustment of the capacitive component. Data are expressed as mean ± SE. Significance was tested by Student's t-test, one-way ANOVA, and Dunnett's test where applicable, and P < 0.05 was considered significant.
|
|
RESULTS |
|---|
|
Patterns of cholinergic responses in cTRNs
We studied the cholinergic responses in a major output cell group of the SGI, the cTRNs, which were identified by retrograde labeling from the contralateral brain stem gaze center. To test the desensitization and rundown of cholinergic receptors, we examined the effect of repeated application of CCh on the peak amplitudes of the inward currents. When CCh was applied at 15-min intervals, the peak amplitudes of inward currents was slightly reduced to 94.11 ± 0.81 and 91.44 ± 0.51% after two and three repeated applications, respectively (P < 0.01, ANOVA and Dunnett's test, n = 4; Fig. 2 Ab). This result indicates that our procedure of CCh application exhibited slight desensitization and rundown. Thus we chose the application of CCh at 15-min intervals in the following experiments. In all the cTRNs tested (24/24), bath application of 30 µM CCh elicited current response at the holding potential of –70 mV in the solution containing 0.5 µM TTX, 10 µM CNQX, 50 µM APV, and 10 µM Bic. Among these cTRNs, 11 neurons (46%) exhibited inward currents with a relatively fast onset and a slow declining phase. When pretreated the neurons with 1 µM DHβE, the peak response was significantly decreased. The remaining inward current with a relatively slow onset and slow declining phase was completely suppressed by 1 µM atropine (Fig. 2A1a). Thus these cTRNs exhibited relatively fast inward currents mediated by nAChRs and slow inward currents by mAChRs [nicotinic inward (nIN) + muscarinic inward (mIN) current response]. In the remaining 13 cTRNs (54%), CCh induced an inward current with a relatively fast onset and a slow declining phase. In the presence of 1 µM DHβE, CCh induced a mixture of slow inward and slow outward currents in which the inward current predominated (Fig. 2A2a) or the slow outward current appeared to override the smaller and slower inward current (Fig. 2A2b). Both of the remaining slow inward and outward currents completely disappeared when the neuron was pretreated with 1 µM atropine. Therefore these cTRNs exhibited relatively fast inward currents mediated by nAChRs and slow inward and outward currents mediated by mAChRs [nicotinic inward (nIN) + muscarinic inward (mIN) + muscarinic outward (mOUT) current response]. Typical examples of the morphology of these cTRNs that exhibited the nIN + mIN current responses and nIN + mIN + mOUT current responses are shown in Fig. 2B. Both of these types of cells possessed relatively large soma and multipolar dendrites. In some cells, the axons were found to leave the SC and traveled along the outer border of the periaqueductal gray matter, a typical axonal course of cTRNs (Fig. 2Bd). Regular spiking was a major firing pattern in both cTRNs exhibited nIN + mIN (9/11) and nIN + mIN + mOUT (9/13) current responses. When we compared the neurons with the above two types of the cholinergic responses, there were no significant differences in somatic area [281.9 ± 32.94 (neurons with nIN + mIN, n = 11) vs. 265.8 ± 17.55 µm2 (neurons with nIN + mIN + mOUT, n = 11), P = 0.67, Student's t-test], membrane capacitance [37.45 ± 3.24 (neurons with nIN + mIN, n = 11) vs. 43.14 ± 2.87 pF (neurons with nIN + mIN + mOUT, n = 13), P = 0.20], and input impedance [460.7 ± 73.93 (neurons with nIN + mIN, n = 11) vs. 418.5 ± 59.98 M
(neurons with nIN + mIN + mOUT, n = 13), P = 0.66].
|
The pharmacological properties of nAChR-mediated current responses in cTRNs were examined in the second series of experiments. The experiments were performed using Cs gluconate–based intrapipette solution to block the current mediated by K+ channels. Brief pressure applications of 1 mM ACh (20–30 psi, 30- to 50-ms duration) in the presence of 1 µM atropine induced inward currents in all the tested cTRNs (58/58) at the holding potential of –70 mV (Fig. 3). There were two types of current responses: a slow inward current only and a fast and slow inward current. First, we examined the effect of repeated application of ACh on the peak amplitudes of the inward currents. The peak amplitude of the slow inward currents induced by ACh applied at 1-min intervals was slightly reduced to 98.14 ± 0.53, 96.14 ± 1.32, and 93.62 ± 0.99% after 10, 20, and 25 min of repeated applications, respectively (ANOVA and Dunnett's test, n = 5; Fig. 3, A and B). The fast component of the inward currents induced by ACh, applied at 1-min intervals, was also reduced to 88.03 ± 1.86, 80.63 ± 1.39, and 70.07 ± 4.62% after 10, 20, and 25 min of repeated applications, respectively (ANOVA and Dunnett's test, n = 3; Fig. 3, E and F). These results indicate that our procedure of ACh application exhibited slight desensitization and rundown. Thus we chose the application of ACh at 1-min intervals in the following experiments. In the majority of the tested cTRNs (90%, 52/58), the nIN was only slightly suppressed by 100 nM
-BTX, a specific antagonist for the
7 receptor subtype, and 50 nM
-CTX MII, a specific antagonist for the
3/
6β2 receptor subtype, although 200 nM DHβE, a specific antagonist for
4β2 subtype of nAChRs, almost completely inhibited these currents after 4 min of application (Fig. 3, C and D). The mean peak amplitude was reduced to 2.25 ± 0.25% of the control ACh response (P < 0.001, ANOVA and Dunnett's test). In the remaining 6/58 cTRNs (10%), the nicotinic inward currents exhibited two components: a faster one and a slower one (Fig. 3, E and G). The faster inward current component was inhibited by 100 nM
-BTX (Fig. 3, G and H). The mean peak amplitude of the fast current component was reduced to 25.3 ± 5.67% of the control ACh response (P < 0.001). The remaining current component was not suppressed by 50 nM
-CTX MII but was further inhibited by 200 nM DHβE to 0.92 ± 0.34% (P < 0.001). When we compared the membrane capacitance and the somatic area of the neurons with the above two types of pharmacological profiles, it was found that neurons with a DHβE-sensitive component only had higher membrane capacitance than
-BTX- plus DHβE-sensitive neurons [38.75 ± 1.42 (neurons with DHβE-sensitive component only; n = 52) vs. 29.47 ± 2.35 pF (neurons with
-BTX- plus DHβE-sensitive components, n = 6), P < 0.05, Student's t-test] and larger somatic area [267.1 ± 9.24 (neurons with DHβE-sensitive component only, n = 44) vs. 162.0 ± 11.9 µm2 (neurons with
-BTX–plus DHβE-sensitive components, n = 6), P < 0.01]. These results indicate that the nIN current response in cTRNs was mediated mainly by the
4β2 nAChRs and partly by
7 nAChRs. Moreover, the cTRNs that expressed mainly
4β2 nAChR possessed larger soma size than those expressing both
7 and
4β2 nAChRs.
|
In the third series of experiments, we examined the pharmacological properties of mAChR-mediated current responses in cTRNs. The experiments were performed using K gluconate–based intrapipette solution to allow K+ currents through potassium channels that might be induced by activation of mAChRs. Bath application of 10 µM muscarine induced inward or inward + outward currents in all the cTRNs tested (38/38) at the holding potential of –70 mV. Similar to the muscarinic currents induced by bath application of CCh, muscarine induced only two response patterns: mIN current only (45%, 17/38) and mIN + mOUT currents (55%, 21/38).
First, we studied the subtypes of mAChRs in neurons with mIN only responses (n = 17) by applying muscarine along with specific mAChR antagonists. Then, mIN could be almost completely suppressed by 50 nM DAMP, a specific M3 receptor antagonist, in a majority of this neuron group (65%, 11/17; Fig. 4, A and B). The averaged peak amplitude of inward currents induced by muscarine was decreased to 5.18 ± 1.49% of the control muscarine response (P < 0.001, ANOVA and Dunnett's test). The effects of 10 µM methoctramine, a specific M2 receptor antagonist, and 1 µM pirenzepine, a specific M1 receptor antagonist, were very small, if any (Fig. 4, A and B). In the remaining 6/17 neurons (35%), muscarine-induced inward current was partly suppressed by both 1 µM pirenzepine and 50 nM DAMP but not by 10 µM methoctramine (Fig. 4, C and D). The mean peak amplitude of these inward currents was reduced to 60.83 ± 7.13 and 6.83 ± 0.79% of the control muscarine response after pretreating the neurons for >5 min with pirenzepine (P < 0.01) and DAMP (P < 0.001), respectively. These results indicate that the mIN in cTRNs is mediated mainly by M3 subtype of the mAChRs. However, M1 receptors also contribute to the inward currents by co-activation with the M3 receptors in a subpopulation of these neurons.
|
|
|
|
DISCUSSION |
|---|
|
Previous studies showed that there are several subsystems in the tectofugal pathways. For instance, Dean et al. (1989)
showed that the contralateral tecto-bulbar pathway is involved in the control of orienting behaviors, whereas the ipsilateral tecto-reticular pathway is involved in avoidance behaviors. In addition, some tectofugal neurons have ascending projections to the thalamus and meso-diencephalic junctional regions (Grantyn and Grantyn 1982
; Huerta and Harting 1982
). More recent studies showed tectal projections to the dopaminergic neurons in the substantia nigra pars compacta (Comoli et al. 2003
; McHaffie et al. 2006
), which were found to be collaterals of the ascending projections to the thalamus (Coizet et al. 2007
). Moreover, some of the tectofugal neurons were found to be GABAergic neurons (May et al. 2005
; Sooksawate et al. 2005a
).
In this study, we focused on the action of cholinergic inputs to one defined subclass of neurons in the SGI of the rat SC projecting to the brain stem gaze center: cTRNs. They send the descending command for orienting behaviors (Dean et al. 1989
; Grantyn and Berthoz 1985
). We identified these neurons using retrograde labeling of fluorescent tracer, dextran-conjugated Texas red, injected into the contralateral MPRF. As shown in Fig. 2A, the cholinergic responses to bath application of CCh in this group of neurons had only two patterns: 1) nIN + mIN and 2) nIN + mIN + mOUT. This result suggests that a major response to cholinergic input to cTRNs would be excitatory. As we reported in our recent study (Sooksawate and Isa 2006
), we found five cholinergic response patterns in randomly sampled SGI neurons: 1) nIN only, 2) nIN + mIN, 3) nIN + mIN + mOUT, 4) nIN + mOUT, and 5) mOUT only. In that study, some of the recorded neurons were identified as projection neurons because they were found to issue at least one of their axon collaterals to outside the SC with biocytin staining. In these populations of projection neurons, we found the above 1), 2), 3), and 4) response patterns. The results from this study and the former one suggest that there are at least more than two groups of projection neurons in the SGI that may differently respond to cholinergic inputs.
Functional nAChR subtypes involved in the current responses
Brief pressure application of ACh, in the presence of 1 µM atropine, was used to clarify the nAChR subtypes that mediated the nIN in cTRNs. This rapid application was fast enough to induce the fast desensitizing current component caused by
7 nAChR subtype (Albuquerque et al. 1997
; Endo et al. 2005
; Sooksawate and Isa 2006
). In this study, we found that nIN was sensitive to 200 nM DHβE, a selective antagonist to
4β2 receptors, in all the cTRNs tested (100%, 58/58; Fig. 3), and additionally, that a subset of cTRNs (10%, 6/58) exhibited a faster current component that was sensitive to
-BTX, an antagonist of
7 nAChRs (Fig. 3, G and H). In this study, we did not find a neuron whose nicotinic current was sensitive to
-CTX MII, a selective antagonist to
3/
6β2 receptors. When these results are compared with those obtained from randomly sampled SGI neurons, it is noticeable that the ratio of SGI neurons that co-expressed both
4β2 and
7 receptors was higher (18%; 8/45) among the randomly sampled population. In addition 1/45 neuron was sensitive to
-CTX MII in those populations (Sooksawate and Isa 2006
), which suggests that nonprojection neurons of the SGI express
7 or
3/
6β2 receptors with a higher ratio than the cTRNs. The role of the nAChRs in modulation of the network activity requires more argument. This study showed that
4β2 receptors were activated by the bath application of CCh, whereas
7 receptors were not. Therefore it is still unclear whether
7 receptors can have any role in modulation of the network activity. The answer depends on how ACh is released from the presynaptic terminals innervating the SGI and reaches the receptors, that is, whether ACh is released transiently in fast synaptic action or released with slow kinetics and acts on synapses with volume transmission, which is unclear at this moment.
Functional mAChR subtypes involved in the current responses
Bath application of muscarine induced only two response patterns, inward current only (45%, 17/38) and inward + outward currents (55%, 21/38), in cTRNs in a similar manner to the muscarinic currents induced by bath application of CCh. It was clarified that, in cTRNs of mIN only pattern, M3 receptors mediate the inward currents in 11/17 cTRNs, whereas M1 receptors also seemed to be involved in mediating the mIN in the remaining 6 cTRNs (35%). Also in the case of the cTRNs expressing both mIN and mOUT, 50 nM DAMP was highly sensitive to inhibit these inward currents in the majority of cTRNs tested (14/17; Fig. 5, C and D). In the remaining 3/17 neurons, the inward currents seemed to be mediated both by M1 and M3 mAChRs (Fig. 5, E and F). These results confirmed our previous paper studied in randomly sampled SGI neurons (Sooksawate and Isa 2006
).
Comparison with cholinergic inputs to the superficial layers: functional implication
It has been shown that the superficial layers (sSC) of the SC receive cholinergic inputs from the nucleus parabigeminalis (Graybiel 1978b
; Hall et al. 1989
; Sherk 1979
; Watanabe and Kawana 1979
). The cholinergic input from this nucleus may stimulate presynaptic terminals to potentiate the release of glutamate onto the SGS inhibitory neurons (Binns and Salt 2000
). The previous report from our laboratory also tested the function of nAChRs by a transient pressure application of ACh in the superficial layers (sSC) of the mouse SC (Endo et al. 2005
). In that study, ACh application induced transient inward current response followed by a burst of synaptic currents mediated by GABAA receptors in most of the non-GABAergic neurons. Because the GABAergic synaptic currents could be activated under the presence of TTX, they were supposed to be induced by facilitation of GABA release by activation of nAChRs in the presynaptic GABAergic neurons. The GABAergic neurons in the sSC were found to express
-CTX MII-sensitive nAChRs,
3/
6β2 subtype nAChRs, and partly
-BTX–sensitive,
7 subtype nAChRs. Thus the major action of nACh activation was supposed to be facilitation of GABAergic transmission that might be involved in enhancement of contrast sensitivity of sSC neuron.
On the other hand, preliminary previous report by Kobayashi and Isa (2002)
showed that CCh and nicotine could induce depolarization and spike firing in SGI neurons and cTRNs, respectively. These results also suggested that a possible role of cholinergic input to cTRNs is facilitation of orienting behaviors including saccadic eye movements. A previous report by Weldon et al. (1983)
showed that injection of CCh into the SC induced rotational behavior contralateral to the injection site and suggested the facilitatory effect of the cholinergic inputs to the SC. Our previous study also showed that injection of nicotine into the SGI facilitated the initiation of saccades (Aizawa et al. 1999
; Watanabe et al. 2005
). Our laboratory previously reported the results of single unit recording from the monkey PPTN during visually guided saccade task (Kobayashi et al. 2002
). In that study, we showed that, when the tonic firing of a population of PPTN neurons during fixation period of the task was high, monkeys correctly performed the task, and when the tonic firing was low, they often failed in performing this task. This may suggest the facilitatory action of cholinergic inputs from the PPTN to the SGI in the control of visually guided saccades.
According to the findings of this study, cholinergic input to the SGI is supposed to facilitate initiation of presaccadic burst activity of cTRNs via the activations of
4β2 subtype and partly by
7 subtype nAChRs and M3 (plus M1) mAChRs on their postsynaptic membranes. Although in some cTRNs, cholinergic agonists induced outward current mediated by M2 mAChRs, the overall effect of the activations of all nAChRs and mAChRs was still the inward current response in these neurons. Further study is needed to examine the functional role of this M2 receptor–mediated outward current in cTRNs. In addition to the postsynaptic facilitatory effect of cholinergic inputs to the projection neurons, a previous study from our group showed that activation of M1 and M3 receptors induced presynaptic inhibition of GABAergic synapses in the SGI (Li et al. 2004
). Several reports have shown that substantia nigra pars reticulata (Hikosaka and Wurtz 1985
) and fixation zone in the SC rostral pole (Meredith and Ramoa 1998
; Munoz and Wurtz 1992
) sent a tonic GABAergic inhibition to the presaccadic burst neurons including projection neurons in the SGI. In this regard, therefore postsynaptic depolarization and presynaptic inhibition of tonic GABAergic inhibition would bring the membrane potential of cTRNs close to the threshold for the NMDA receptor (NMDAR)-dependent burst firing (Saito and Isa 2003
, 2004
; Sooksawate et al. 2005b
). This would facilitate the animals to respond rapidly to extrinsic stimuli. On the other hand, if the cholinergic input to SGI is weak, tonic excitation of the cTRNs and the decrease of tonic GABAergic inhibition may not be sufficient to facilitate the NMDAR-dependent burst firing. This will make animals difficult to respond to the extrinsic stimuli.
As we showed above, different subclasses of SGI neurons may differently respond to cholinergic inputs. To further elucidate the mechanisms by which cholinergic inputs influences the local circuit activity in the SC, we need to examine the effects of cholinergic agonists and antagonists in other subclasses of SGI neurons, including GABAergic neurons (Lee et al. 2007
; Sooksawate et al. 2005a
). These results will help us to understand more how the cholinergic inputs to SGI from the parabrachial region of the brain stem modulate the various aspects of SC functions.
|
|
GRANTS |
|---|
|
|
|
ACKNOWLEDGMENTS |
|---|
|
|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: T. Isa, Dept. of Developmental Physiology, National Inst. for Physiological Sciences, Myodaiji, Okazaki 444-8585, Japan (E-mail: tisa{at}nips.ac.jp)
|
|
REFERENCES |
|---|
|
Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117–1136, 1997.
Beninato M, Spencer RF. A cholinergic projection to the rat superior colliculus demonstrated by retrograde transport of horseradish peroxidase and choline acetyltransferase immunohistochemistry. J Comp Neurol 253: 525–538, 1986.[CrossRef][Web of Science][Medline]
Binns KE, Salt TE. The functional influence of nicotinic cholinergic receptors on the visual responses of neurons in the superficial superior colliculus. Vis Neurosci 17: 283–289, 2000.[CrossRef][Web of Science][Medline]
Boller M, Schmidt M. GABAC receptors in the rat superior colliculus and pretectum participate in synaptic neurotransmission. J Neurophysiol 89: 2035–2045, 2003.
Boue-Grabot E, Roudbaraki M, Bascies L, Tramu G, Bloch B, Garret M. Expression of GABAC receptor
subunits in rat brain. J Neurochem 70: 899–907, 1998.[Web of Science][Medline]
Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-
-bungarotoxin. J Neurosci 5: 1307–1315, 1985.[Abstract]
Coizet V, Paul G, Overton PG, Redgrave P. Collateralization of the tectonigral projection with other major output pathways of superior colliculus in the rat. J Comp Neurol 500: 1034–1049, 2007.[CrossRef][Web of Science][Medline]
Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG, Redgrave P. A direct projection from superior colliculus to substantia nigra for detecting salient visual events. Nat Neurosci 6: 974–980, 2003.[CrossRef][Web of Science][Medline]
Cortes R, Probst A, Palacios JM. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: brainstem. Neuroscience 12: 1003–1026, 1984.[Medline]
Cymerman U, Palacios JM, Cortes R, Skangiel-Kramska J. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine. Neurosci Lett 81: 13–18, 1987.[CrossRef][Web of Science][Medline]
Dean P, Redgrave P, Westby GW. Event or emergency? Two response systems in the mammalian superior colliculus. Trends Neurosci 12: 137–147, 1989.[CrossRef][Web of Science][Medline]
Dominguez del Toro E, Juiz JM, Peng X, Lindstrom J, Criado M. Immunocytochemical localization of the alpha 7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol 349: 325–342, 1994.[CrossRef][Web of Science][Medline]
Endo T, Yanagawa Y, Obata K, Isa T. Nicotinic acetylcholine receptor subtypes involved in facilitation of GABAergic inhibition in mouse superficial superior colliculus. J Neurophysiol 94: 3893–3902, 2005.
Frey KA, Howland MM. Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: distinction of receptor subtypes in antagonist competition assays. J Pharmacol Exp Ther 263: 1391–1400, 1992.
Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27: 482–491, 2006.[CrossRef][Medline]
Grantyn A, Berthoz A. Burst activity of identified tecto-reticulo-spinal neurons in the alert cat. Exp Brain Res 57: 417–421, 1985.[Web of Science][Medline]
Grantyn A, Grantyn R. Axonal patterns and sites of termination of cat superior colliculus neurons projecting in the tecto-bulbo-spinal tract. Exp Brain Res 46: 243–256, 1982.[Web of Science][Medline]
Graybiel AM. A stereometric pattern of distribution of acetylthiocholinesterase in the deep layers of the superior colliculus. Nature 272: 539–541, 1978a.
Graybiel AM. A satellite system of the superior colliculus: the parabigeminal nucleus and its projections to the superficial collicular layers. Brain Res 45: 365–374, 1978b.[CrossRef]
Hall WC, Fitzpatrick D, Klatt LL, Raczkowski D. Cholinergic innervation of the superior colliculus in the cat. J Comp Neurol 287: 495–514, 1989.[CrossRef][Web of Science][Medline]
Hikosaka O, Wurtz RH. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata. J Neurophysiol 53: 292–308, 1985.
Hoss W, Woodruff JM, Ellerbrock BR, Periyasamy S, Ghodsi-Hovsepian S, Stibbe J, Bohnett M, Messer WS Jr. Biochemical and behavioral responses of pilocarpine at muscarinic receptor subtypes in the CNS. Comparison with receptor binding and low-energy conformations. Brain Res 533: 232–238, 1990.[CrossRef][Web of Science][Medline]
Huerta MF, Harting JK. Tectal control of spinal cord activity: neuroanatomical demonstration of pathways connecting the superior colliculus with the cervical spinal cord grey. Prog Brain Res 57: 293–328, 1982.[Web of Science][Medline]
Illing RB, Graybiel AM. Convergence of afferents from frontal cortex and substantia nigra onto acetylcholinesterase-rich patches of the cat's superior colliculus. Neuroscience 14: 455–482, 1985.[CrossRef][Web of Science][Medline]
Isa T, Endo T, Saito Y. The visuo-motor pathway in the local circuit of the rat superior colliculus. J Neurosci 18: 8496–8504, 1998.
Isa T, Sasaki S. Brainstem control of head movements during orienting; organization of the premotor circuits. Prog Neurobiol 66: 205–241, 2002.[CrossRef][Web of Science][Medline]
King AJ. The superior colliculus. Curr Biol 14: R335–R338, 2004.[CrossRef][Web of Science][Medline]
Kobayashi Y, Inoue Y, Yamamoto M, Isa T, Aizawa H. Contribution of pedunculopontine tegmental nucleus neurons to performance of visually guided saccade tasks in monkeys. J Neurophysiol 88: 715–731, 2002.
Kobayashi Y, Isa T. Sensory-motor gating and cognitive control by the brainstem cholinergic system. Neural Networks 15: 731–741, 2002.[CrossRef][Web of Science][Medline]
Lee P, Sooksawate T, Yanagawa Y, Isa K, Isa T, Hall WC. Identity of a pathway for saccadic suppression. Proc Natl Acad Sci USA 104: 6824–6827, 2007.
Levey AI. Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52: 441–448, 1993.[CrossRef][Web of Science][Medline]
Li F, Endo T, Isa T. Presynaptic muscarinic acetylcholine receptors suppress GABAergic synaptic transmission in the intermediate grey layer of mouse superior colliculus. Eur J Neurosci 20: 2079–2088, 2004.[CrossRef][Web of Science][Medline]
Ma TP, Graybiel AM, Wurtz RH. Location of saccade-related neurons in the macaque superior colliculus. Exp Brain Res 85: 21–35, 1991.[Web of Science][Medline]
May PJ, Perkins E, Zhou L, Warren S. Macaque central mesencephalic reticular formation connections underlying-collicular control of gaze. Soc Neurosci Abstr 31: 858.4, 2005.
McHaffie JG, Jiang H, May PJ, Coizet V, Overton PG, Stein BE, Redgrave P. A direct projection from superior colliculus to substantia nigra pars compacta in the cat. Neuroscience 138: 221–234, 2006.[CrossRef][Web of Science][Medline]
Meredith MA, Ramoa AS. Intrinsic circuitry of the superior colliculus: pharmacophysiological identification of horizontally oriented inhibitory interneurons. J Neurophysiol 79: 1597–1602, 1998.
Miyoshi R, Kito S, Shimoyama M. Quantitative autoradiographic localization of the M1 and M2 subtypes of muscarinic acetylcholine receptors in the monkey brain. Jpn J Pharmacol 51: 247–255, 1989.[CrossRef][Medline]
Munoz DP, Wurtz RH. Role of the rostral superior colliculus in active visual fixation and execution of express saccades. J Neurophysiol 67: 1000–1002, 1992.
Nguyen HN, Rasmussen BA, Perry DC. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment. J Neurochem 90: 40–49, 2004.[Web of Science][Medline]
Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, Kellar KJ. Chronic nicotine differentially regulates
6- and β3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322: 306–315, 2007.
Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468–481, 2002.[CrossRef][Web of Science][Medline]
Price M, Messer WS Jr, Hoss W. Regional distribution of muscarinic receptors preferring gallamine in the rat brain. Biochem Pharmacol 35: 4171–4176, 1986.[CrossRef][Web of Science][Medline]
Prusky GT, Cynader MS. [3H]nicotine binding sites are associated with mammalian optic nerve terminals. Vis Neurosci 1: 245–248, 1988.[Web of Science][Medline]
Saito Y, Isa T. Electrophysiological and morphological properties of neurons in the rat superior colliculus. I. Neurons in the intermediate layer. J Neurophysiol 82: 754–767, 1999.
Saito Y, Isa T. Voltage-gated transient outward currents in neurons with different firing patterns in rat superior colliculus. J Physiol 528: 91–105, 2000.
Saito Y, Isa T. Local excitatory network and NMDA receptor activation generate a synchronous and bursting command from the superior colliculus. J Neurosci 23: 5854–5864, 2003.
Saito Y, Isa T. Laminar specific distribution of lateral excitatory connections in the rat superior colliculus. J Neurophysiol 92: 3500–3510, 2004.
Sherk H. Connections and visual-field mapping in cat's tectoparabigeminal circuit. J Neurophysiol 42: 1656–1668, 1979.
Sooksawate T, Isa T. Properties of cholinergic responses in neurons in the intermediate grey layer of rat superior colliculus. Eur J Neurosci 24: 3096–3108, 2006.[CrossRef][Web of Science][Medline]
Sooksawate T, Isa K, Obata K, Yanagawa Y, Isa T. Electrophysiological and morphological properties of GABAergic neurons in the intermediate gray layer of superior colliculus in GAD67-GFP knock-in mice. Soc Neurosci Abstr 31: 167.8, 2005a.
Sooksawate T, Saito Y, Isa T. Electrophysiological and morphological properties of identified crossed tecto-reticular neurons in the rat superior colliculus. Neurosci Res 52: 174–184, 2005b.[CrossRef][Web of Science][Medline]
Swanson LW, Simmons DM, Whiting PJ, Lindstrom J. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci 7: 3334–3342, 1987.[Abstract]
Tribollet E, Bertrand D, Marguerat A, Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 12: 405–420, 2004.
Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284: 314–335, 1989.[CrossRef][Web of Science][Medline]
Watanabe K, Kawana E. Efferent projections of the parabigeminal nucleus in rats: a horseradish peroxidase (HRP) study. Brain Res 168: 1–11, 1979.[CrossRef][Web of Science][Medline]
Watanabe M, Kobayashi Y, Inoue Y, Isa T. Effects of local nicotinic activation of the superior colliculus on saccades in monkeys. J Neurophysiol 93: 519–534, 2005.
Weldon DA, Calabrese LC, Nicklaus KJ. Rotational behavior following cholinergic stimulation of the superior colliculus in rats. Pharmacol Biochem Behav 19: 813–820, 1983.[CrossRef][Web of Science][Medline]
Whiteaker P, McIntosh JM, Luo S, Collins AC, Marks MJ. 125I-
-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol 57: 913–925, 2000.
Whiteaker P, Peterson CG, Xu W, McIntosh JM, Paylor R, Beaudet AL, Collins AC, Marks MJ. Involvement of the
3 subunit in central nicotinic binding populations. J Neurosci 22: 2522–2529, 2002.
Zubieta JK, Frey KA. Autoradiographic mapping of M3 muscarinic receptors in the rat brain. J Pharmacol Exp Ther 264: 415–422, 1993.
This article has been cited by other articles:
![]() |
T. Isa and W. C. Hall Exploring the Superior Colliculus In Vitro J Neurophysiol, November 1, 2009; 102(5): 2581 - 2593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ye, A. Hayar, and E. Garcia-Rill Cholinergic Responses and Intrinsic Membrane Properties of Developing Thalamic Parafascicular Neurons J Neurophysiol, August 1, 2009; 102(2): 774 - 785. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |